BrandBuild fuses comprehensive pharmaceutical commercialization experience, local know-how, an extensive partner/alliance network and a team of seasoned pharmaceutical experts to deliver exceptional solutions, service and business results.
Our team’s experience includes helping such companies as:
AstraZeneca Canada
- Instrumental in planning and leading the highly successful Canadian launch of megabrand Symbicort to realize the company’s most successful product uptake in category history.
- Planned and implemented effective KOL development initiatives, including clinical training, peer-to-peer functions, lunch-and-learn programs and a 100-person scientific advisory meeting in Arizona.
- Achieved 80% awareness and 90% intent to prescribe across all specialties in 3 months.
- Captured 30% NRx share within 8 weeks of launch and outpaced the growth of the market leader after only 4 months.
Iroko Pharmaceuticals Inc.
- Led the Canadian launch and assumed Canadian commercial responsibility for a US-based pharmaceutical company operating virtually.
- Oversaw all aspects of company operations and the branding of two product entries (Vancocin), including pricing, sales and marketing.
- Led KOL development, hospital contracting process, buying group sales and collaboration with trade and regulatory partners.
- Delivered a 22% increase in top line sales of a mature, non-promoted brand in 18 months.
- Optimized price ahead of Loss of Exclusivity (LOE).
- Directed reimbursement and hospital formulary submissions while achieving “Exceptional status” listing in Ontario.
Client: Concordia Healthcare Corp.
- Oversaw all of the company’s commercial functions in the US including sales, business development, market/channel development marketing, brand strategy, pricing and life cycle optimization of three acquired legacy products with peak sales of $100M+ usd;
- Managed all service partners (including marketing services vendors and the original portfolio vendors) to successfully migrate three product portfolio to the US business.
- Established outline of corporate policies to ensure compliance with state/federal reporting and appropriate transparency.
- Developed market expansion and launch plans for legacy products in Canada.
- Worked with trade and manufacturers to identify improved profitability and margins on mature assets.
Oryx Pharmaceuticals Inc.
- From startup, planned and directed the launch of a specialty pharmaceutical company and two products that generated approximately $10M in sales.
- Conducted a detailed analysis of numerous product for in-licensing in the Canadian Specialty pharmaceutical market.
- Led the redesign of sales organization of specialty Canadian pharmaceutical company that commercialized prescription and hospital products through purchasing, licensing and development with a focus in the cardiovascular, central nervous system (CNS) disorders, pain and infectious disease therapeutic areas.
- Used contemporary software and developed high portfolio-specific criteria for improved territory alignment and sales force allocation.
- Developed strategic recommendations that decreased annual sales costs by 15%.
Manna X Corporation
- Provided interim GM leadership for the manufacturer of Advantage+ dietary supplements for immune support and athletic performance.
- Developed the company’s business plan and selling model and helped to secure investment.
- Built Canadian distribution and optimized supply relationships.
- Led market segmentation, planned line extensions and established improved processes across core business functions.
Alden Connectiv Inc.
- Launched an innovative proprietary web key technology serving healthcare and additional sectors.
- Planned and led North American business development and marketing strategies for a company that combines digital and print media to optimize reach and drive trial/adoption of healthcare solutions through improved access to digital resources.